Pulmonary Embolism Drug Market - Global Outlook and Forecast 2021-2027

Code: RW00014560614
Market Monitor Global
Oct-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Pulmonary Embolism Drug in global, including the following market information:
Global Pulmonary Embolism Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Pulmonary Embolism Drug Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Pulmonary Embolism Drug companies in 2020 (%)
The global Pulmonary Embolism Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary Embolism Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Embolism Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pulmonary Embolism Drug Market Segment Percentages, By Type, 2020 (%)
DS-9231
DS-1040
TRX-1
Others

Global Pulmonary Embolism Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pulmonary Embolism Drug Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others

Global Pulmonary Embolism Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pulmonary Embolism Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Embolism Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Pulmonary Embolism Drug revenues share in global market, 2020 (%)
Key companies Pulmonary Embolism Drug sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Pulmonary Embolism Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Accu-Break Pharmaceuticals, Inc.
Dong-A Socio Holdings Co. Ltd.
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Verseon Corp

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Pulmonary Embolism Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Embolism Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Embolism Drug Overall Market Size
2.1 Global Pulmonary Embolism Drug Market Size: 2021 VS 2027
2.2 Global Pulmonary Embolism Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Pulmonary Embolism Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Pulmonary Embolism Drug Players in Global Market
3.2 Top Global Pulmonary Embolism Drug Companies Ranked by Revenue
3.3 Global Pulmonary Embolism Drug Revenue by Companies
3.4 Global Pulmonary Embolism Drug Sales by Companies
3.5 Global Pulmonary Embolism Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pulmonary Embolism Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Pulmonary Embolism Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Embolism Drug Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Embolism Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Embolism Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Embolism Drug Market Size Markets, 2021 & 2027
4.1.2 DS-9231
4.1.3 DS-1040
4.1.4 TRX-1
4.1.5 Others
4.2 By Type - Global Pulmonary Embolism Drug Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Embolism Drug Revenue, 2016-2021
4.2.2 By Type - Global Pulmonary Embolism Drug Revenue, 2022-2027
4.2.3 By Type - Global Pulmonary Embolism Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Pulmonary Embolism Drug Sales & Forecasts
4.3.1 By Type - Global Pulmonary Embolism Drug Sales, 2016-2021
4.3.2 By Type - Global Pulmonary Embolism Drug Sales, 2022-2027
4.3.3 By Type - Global Pulmonary Embolism Drug Sales Market Share, 2016-2027
4.4 By Type - Global Pulmonary Embolism Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Embolism Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Pulmonary Embolism Drug Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Embolism Drug Revenue, 2016-2021
5.2.2 By Application - Global Pulmonary Embolism Drug Revenue, 2022-2027
5.2.3 By Application - Global Pulmonary Embolism Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Pulmonary Embolism Drug Sales & Forecasts
5.3.1 By Application - Global Pulmonary Embolism Drug Sales, 2016-2021
5.3.2 By Application - Global Pulmonary Embolism Drug Sales, 2022-2027
5.3.3 By Application - Global Pulmonary Embolism Drug Sales Market Share, 2016-2027
5.4 By Application - Global Pulmonary Embolism Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Pulmonary Embolism Drug Market Size, 2021 & 2027
6.2 By Region - Global Pulmonary Embolism Drug Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Embolism Drug Revenue, 2016-2021
6.2.2 By Region - Global Pulmonary Embolism Drug Revenue, 2022-2027
6.2.3 By Region - Global Pulmonary Embolism Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Pulmonary Embolism Drug Sales & Forecasts
6.3.1 By Region - Global Pulmonary Embolism Drug Sales, 2016-2021
6.3.2 By Region - Global Pulmonary Embolism Drug Sales, 2022-2027
6.3.3 By Region - Global Pulmonary Embolism Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Pulmonary Embolism Drug Revenue, 2016-2027
6.4.2 By Country - North America Pulmonary Embolism Drug Sales, 2016-2027
6.4.3 US Pulmonary Embolism Drug Market Size, 2016-2027
6.4.4 Canada Pulmonary Embolism Drug Market Size, 2016-2027
6.4.5 Mexico Pulmonary Embolism Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Pulmonary Embolism Drug Revenue, 2016-2027
6.5.2 By Country - Europe Pulmonary Embolism Drug Sales, 2016-2027
6.5.3 Germany Pulmonary Embolism Drug Market Size, 2016-2027
6.5.4 France Pulmonary Embolism Drug Market Size, 2016-2027
6.5.5 U.K. Pulmonary Embolism Drug Market Size, 2016-2027
6.5.6 Italy Pulmonary Embolism Drug Market Size, 2016-2027
6.5.7 Russia Pulmonary Embolism Drug Market Size, 2016-2027
6.5.8 Nordic Countries Pulmonary Embolism Drug Market Size, 2016-2027
6.5.9 Benelux Pulmonary Embolism Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Pulmonary Embolism Drug Revenue, 2016-2027
6.6.2 By Region - Asia Pulmonary Embolism Drug Sales, 2016-2027
6.6.3 China Pulmonary Embolism Drug Market Size, 2016-2027
6.6.4 Japan Pulmonary Embolism Drug Market Size, 2016-2027
6.6.5 South Korea Pulmonary Embolism Drug Market Size, 2016-2027
6.6.6 Southeast Asia Pulmonary Embolism Drug Market Size, 2016-2027
6.6.7 India Pulmonary Embolism Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Pulmonary Embolism Drug Revenue, 2016-2027
6.7.2 By Country - South America Pulmonary Embolism Drug Sales, 2016-2027
6.7.3 Brazil Pulmonary Embolism Drug Market Size, 2016-2027
6.7.4 Argentina Pulmonary Embolism Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Embolism Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Pulmonary Embolism Drug Sales, 2016-2027
6.8.3 Turkey Pulmonary Embolism Drug Market Size, 2016-2027
6.8.4 Israel Pulmonary Embolism Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Pulmonary Embolism Drug Market Size, 2016-2027
6.8.6 UAE Pulmonary Embolism Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Accu-Break Pharmaceuticals, Inc.
7.1.1 Accu-Break Pharmaceuticals, Inc. Corporate Summary
7.1.2 Accu-Break Pharmaceuticals, Inc. Business Overview
7.1.3 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Major Product Offerings
7.1.4 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Sales and Revenue in Global (2016-2021)
7.1.5 Accu-Break Pharmaceuticals, Inc. Key News
7.2 Dong-A Socio Holdings Co. Ltd.
7.2.1 Dong-A Socio Holdings Co. Ltd. Corporate Summary
7.2.2 Dong-A Socio Holdings Co. Ltd. Business Overview
7.2.3 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Major Product Offerings
7.2.4 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Sales and Revenue in Global (2016-2021)
7.2.5 Dong-A Socio Holdings Co. Ltd. Key News
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
7.3.3 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Sales and Revenue in Global (2016-2021)
7.3.5 F. Hoffmann-La Roche Ltd. Key News
7.4 Genentech, Inc.
7.4.1 Genentech, Inc. Corporate Summary
7.4.2 Genentech, Inc. Business Overview
7.4.3 Genentech, Inc. Pulmonary Embolism Drug Major Product Offerings
7.4.4 Genentech, Inc. Pulmonary Embolism Drug Sales and Revenue in Global (2016-2021)
7.4.5 Genentech, Inc. Key News
7.5 Verseon Corp
7.5.1 Verseon Corp Corporate Summary
7.5.2 Verseon Corp Business Overview
7.5.3 Verseon Corp Pulmonary Embolism Drug Major Product Offerings
7.5.4 Verseon Corp Pulmonary Embolism Drug Sales and Revenue in Global (2016-2021)
7.5.5 Verseon Corp Key News
8 Global Pulmonary Embolism Drug Production Capacity, Analysis
8.1 Global Pulmonary Embolism Drug Production Capacity, 2016-2027
8.2 Pulmonary Embolism Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Embolism Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Embolism Drug Supply Chain Analysis
10.1 Pulmonary Embolism Drug Industry Value Chain
10.2 Pulmonary Embolism Drug Upstream Market
10.3 Pulmonary Embolism Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Embolism Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Pulmonary Embolism Drug in Global Market
Table 2. Top Pulmonary Embolism Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Pulmonary Embolism Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Pulmonary Embolism Drug Revenue Share by Companies, 2016-2021
Table 5. Global Pulmonary Embolism Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Pulmonary Embolism Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pulmonary Embolism Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Pulmonary Embolism Drug Product Type
Table 9. List of Global Tier 1 Pulmonary Embolism Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Embolism Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Accu-Break Pharmaceuticals, Inc.
Dong-A Socio Holdings Co. Ltd.
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Verseon Corp

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE